KR102331421B1 - 녹내장의 치료 - Google Patents

녹내장의 치료 Download PDF

Info

Publication number
KR102331421B1
KR102331421B1 KR1020197033872A KR20197033872A KR102331421B1 KR 102331421 B1 KR102331421 B1 KR 102331421B1 KR 1020197033872 A KR1020197033872 A KR 1020197033872A KR 20197033872 A KR20197033872 A KR 20197033872A KR 102331421 B1 KR102331421 B1 KR 102331421B1
Authority
KR
South Korea
Prior art keywords
dextran sulfate
pharmaceutical composition
pharmaceutically acceptable
acceptable salt
glaucoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020197033872A
Other languages
English (en)
Korean (ko)
Other versions
KR20200005560A (ko
Inventor
라스 브루스
아담 브루스
Original Assignee
티엑스 메딕 에이비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 티엑스 메딕 에이비 filed Critical 티엑스 메딕 에이비
Priority claimed from PCT/SE2018/050506 external-priority patent/WO2018212708A1/en
Publication of KR20200005560A publication Critical patent/KR20200005560A/ko
Application granted granted Critical
Publication of KR102331421B1 publication Critical patent/KR102331421B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
KR1020197033872A 2017-05-17 2018-05-16 녹내장의 치료 Active KR102331421B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE1750615 2017-05-17
SE1750615-5 2017-05-17
US201762555848P 2017-09-08 2017-09-08
US62/555,848 2017-09-08
PCT/SE2018/050506 WO2018212708A1 (en) 2017-05-17 2018-05-16 Treatment of glaucoma

Publications (2)

Publication Number Publication Date
KR20200005560A KR20200005560A (ko) 2020-01-15
KR102331421B1 true KR102331421B1 (ko) 2021-11-25

Family

ID=62245395

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020197033872A Active KR102331421B1 (ko) 2017-05-17 2018-05-16 녹내장의 치료

Country Status (12)

Country Link
US (1) US11291684B2 (https=)
EP (1) EP3532072B1 (https=)
JP (1) JP6817466B2 (https=)
KR (1) KR102331421B1 (https=)
CN (1) CN110621320B (https=)
CA (1) CA3063851C (https=)
DK (1) DK3532072T3 (https=)
ES (1) ES2777836T3 (https=)
IL (1) IL270362B (https=)
PL (1) PL3532072T3 (https=)
PT (1) PT3532072T (https=)
RU (1) RU2759998C2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3074987A1 (en) * 2017-09-08 2019-03-14 Tx Medic Ab New use of dextran sulfate
GB202008919D0 (en) * 2020-06-11 2020-07-29 Univ Birmingham Polysaccharide conpositions and therapeutic gels
CN115531417B (zh) * 2022-11-14 2024-04-09 青岛海尔生物科技有限公司 ITGA6阳性iPSC源小梁网类细胞在制备治疗高眼压疾病药物中的应用及筛选方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016076780A1 (en) * 2014-11-11 2016-05-19 Tx Medic Ab New dextran sulfate
WO2017018922A1 (en) 2015-07-30 2017-02-02 Tx Medic Ab New use of dextran sulfate

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4238482A (en) * 1978-09-29 1980-12-09 Peyman Gholam A Intraocular infusion irrigation solution and method
DE3705669A1 (de) 1987-02-21 1988-09-01 Thomae Gmbh Dr K Verwendung von dextransulfat zur herstellung eines arzneimittels zur behandlung und prophylaxe von gefaessverengungen und gefaessverschluessen
JPH02223525A (ja) * 1988-11-16 1990-09-05 Takeda Chem Ind Ltd 血管新生阻害剤
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
US5227372A (en) 1990-03-07 1993-07-13 Children's Medical Center Corporation Method for retaining ophthalmological agents in ocular tissues
CA2020199C (en) 1990-06-29 2002-08-20 Daniel Bar-Shalom Uses of sulphated sugars
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
CA2331620A1 (en) 1998-05-11 1999-11-18 The Endowment For Research In Human Biology, Inc. Use of neomycin for treating angiogenesis-related diseases
GB9917092D0 (en) 1999-07-22 1999-09-22 Ml Lab Plc Treatment of angiogenesis-dependent conditions
WO2005110438A2 (en) 2004-04-15 2005-11-24 Massachusetts Institute Of Technology Methods and products related to the intracellular delivery of polysaccharides
SE0401182D0 (sv) 2004-05-05 2004-05-05 Q Med Ab Novel use of a viscoelastic composition
US20060154894A1 (en) 2004-09-15 2006-07-13 Massachusetts Institute Of Technology Biologically active surfaces and methods of their use
WO2007002139A2 (en) 2005-06-22 2007-01-04 The Trustees Of The University Of Pennsylvania Neuroprotection of retinal ganglion cells
US20140186339A1 (en) * 2006-10-27 2014-07-03 Lpath, Inc. Compositions and methods for treating ocular diseases and conditions
US20130273096A1 (en) 2011-10-05 2013-10-17 Bruce A. Daniels Therapeutic Sulfated Polysaccharides, Compositions Thereof, and Methods for Treating Patients
EP3142684A4 (en) * 2014-05-12 2018-05-23 Purdue Research Foundation Selectin and icam/vcam peptide ligand conjugates
WO2015190989A1 (en) 2014-06-12 2015-12-17 Tx Medic Ab The use of dextran sulfate having an average molecular weight below 10000 da for inducing angiogenisis in a subject
CN107137421A (zh) 2017-05-25 2017-09-08 青岛市中心医院 硫酸葡聚糖在制备抑制角膜血管新生药物中的应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016076780A1 (en) * 2014-11-11 2016-05-19 Tx Medic Ab New dextran sulfate
WO2017018922A1 (en) 2015-07-30 2017-02-02 Tx Medic Ab New use of dextran sulfate

Also Published As

Publication number Publication date
PL3532072T3 (pl) 2020-09-21
ES2777836T3 (es) 2020-08-06
EP3532072B1 (en) 2020-01-01
EP3532072A1 (en) 2019-09-04
CA3063851C (en) 2023-09-19
IL270362B (en) 2021-04-29
BR112019024087A2 (pt) 2020-06-02
CN110621320A (zh) 2019-12-27
JP2020519742A (ja) 2020-07-02
RU2019136633A (ru) 2021-06-17
RU2759998C2 (ru) 2021-11-22
KR20200005560A (ko) 2020-01-15
US20210315920A1 (en) 2021-10-14
RU2019136633A3 (https=) 2021-06-17
PT3532072T (pt) 2020-03-05
US11291684B2 (en) 2022-04-05
CA3063851A1 (en) 2018-11-22
JP6817466B2 (ja) 2021-01-20
CN110621320B (zh) 2023-03-17
DK3532072T3 (da) 2020-04-06

Similar Documents

Publication Publication Date Title
Stepp et al. Reduced intraepithelial corneal nerve density and sensitivity accompany desiccating stress and aging in C57BL/6 mice
Browne et al. Connective tissue growth factor is increased in pseudoexfoliation glaucoma
Patel et al. Wnt signaling promotes axonal regeneration following optic nerve injury in the mouse
Hill et al. Decorin reduces intraocular pressure and retinal ganglion cell loss in rodents through fibrolysis of the scarred trabecular meshwork
CN108503690B (zh) 一种促进创伤后组织修复与再生的修复肽及其应用
Mecum et al. Evaluation of corneal damage after lacrimal gland excision in male and female mice
KR102331421B1 (ko) 녹내장의 치료
Yan et al. Smart coating by thermo-sensitive Pluronic F-127 for enhanced corneal healing via delivery of biological macromolecule progranulin
Zhou et al. The role of netrin-1 in the mouse cornea during Aspergillus fumigatus infection
Yuan et al. Ic100, a humanized therapeutic monoclonal anti-asc antibody alleviates oxygen-induced retinopathy in mice
He et al. Association of high-mobility group box-1 with inflammationrelated cytokines in the aqueous humor with acute primary angle-closure eyes
WO2018212708A1 (en) Treatment of glaucoma
Trofimova Molecular mechanisms of retina pathology and ways of its correction
BR112019024087B1 (pt) Uso de sulfato de dextrano ou de um sal farmaceuticamente aceitável do mesmo para tratamento, inibição ou prevenção de glaucoma
KR20220085726A (ko) Bet 단백질을 저해하는 신규한 펩타이드 및 이를 포함하는 안과질환 예방 및 치료용 조성물
Xu et al. Association between anti‐fibrillin‐2 protein induced retinal degeneration via intravitreous delivery and activated TGF‐β signalling in mice
Pastor Jimeno et al. Proliferative vitreoretinopathy: A new concept of disease pathogenesis and practical consequences
Kokkali The role of innate immune activation in experimental glaucoma
Wang et al. Induction of age-related ocular disorders in a mouse model of pulmonary fibrosis
Reina-Torres et al. 10. VEGF expression is elevated in high-flow regions of mouse trabecular meshwork.
WO2024172043A1 (ja) 網膜色素上皮裂孔の治療薬
Sabljic The Role of the Vasculature and Immune System in Models of Glaucoma
Echevarria The Role of Interleukin-6 in Health and Disease of Retinal Ganglion Cells
Biagioni Fighting inflammation to save cones: anti-inflammatory approaches to slow down cone degeneration in a mouse model of retinitis pigmentosa
CN119656201A (zh) 蜗牛粘液提纯物在制备促进角膜上皮损伤愈合的药物中的应用

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20191115

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
A302 Request for accelerated examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20210215

Comment text: Request for Examination of Application

PA0302 Request for accelerated examination

Patent event date: 20210215

Patent event code: PA03022R01D

Comment text: Request for Accelerated Examination

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20210517

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20210923

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20211123

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20211123

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20241105

Start annual number: 4

End annual number: 4